# Effects of mutations in multiple Ethionamide-resistance-associated genes among Mycobacterium tuberculosis clinical isolates from China

**Authors:** Wei Wang, Xiang-long Bo, Ma-chao Li, Shi-qiang Lin, Hai-can Liu, Xue-ting Fan, Xiu-qin Zhao, Kang-Lin Wan, Li-li Zhao

PMC · DOI: 10.3389/fcimb.2025.1725219 · 2026-01-16

## TL;DR

This study examines how mutations in specific genes affect resistance to the TB drug ethionamide in Mycobacterium tuberculosis isolates from China.

## Contribution

The study identifies novel mutations and their association with high-level ethionamide resistance in clinical isolates from China.

## Key findings

- 95.1% of ethionamide-resistant isolates had at least one mutation in ETH resistance-associated genes.
- Multiple mutations were significantly linked to high-level resistance (P = 0.012).
- Novel mutations like inhA -100C>A and mshA Tyr155Ser were detected in resistant strains.

## Abstract

The growing burden of drug-resistant tuberculosis (TB) constitutes a major public health challenge. Ethionamide (ETH), a second-line anti-TB drug, plays an important role in the treatment of multidrug-resistant tuberculosis (MDR-TB). However, the molecular mechanisms underlying ETH resistance remain incompletely elucidated. Thus, this study aimed to evaluate the effects of mutations in ETH resistance-associated genes (inhA, ethA, ethR, and mshA) on ETH resistance levels among Mycobacterium tuberculosis (MTB) isolates from China.

A total of 137 MTB isolates from China were tested for ETH minimum inhibitory concentrations (MICs) pusing Sensititre® plates, and the sequences of four ETH resistance-associated genes were analyzed based on genomic and PCR sequencing data.

Our results showed that 95.1% (39/41 isolates) of ETH-resistant isolates harbored at least one mutation in these four ETH resistance-associated genes. Most mutations were found in the inhA and ethA (including 5’ untranslated region). Mutations in inhA region were mainly concentrated at the -777C>T site, whereas those in the ethA region were relatively scattered. Notably, multiple mutations were common in high-level ETH-resistant strains and were significantly associated with high-level resistance (P = 0.012). Furthermore, several novel single mutations in ETH-resistant strains, including inhA -100C>A, ethA -31G>A, and mshA Tyr155Ser, were detected.

Different individual mutations and multiple concurrent mutations in ETH resistance-associated genes are associated with varying levels of ETH resistance. These results broaden our understanding of the molecular characteristics of ETH resistance in China.

## Linked entities

- **Genes:** INHA (inhibin subunit alpha) [NCBI Gene 3623], SCN9A (sodium voltage-gated channel alpha subunit 9) [NCBI Gene 6335], ETHR (ETHR) [NCBI Gene 42523], mshA (D-inositol 3-phosphate glycosyltransferase) [NCBI Gene 887160]
- **Chemicals:** Ethionamide (PubChem CID 2761171)
- **Diseases:** tuberculosis (MONDO:0018076), drug-resistant tuberculosis (MONDO:0041806), MDR-TB (MONDO:0005861)
- **Species:** Mycobacterium tuberculosis (taxon 1773)

## Full-text entities

- **Diseases:** TB (MESH:D014376), MDR-TB (MESH:D018088)
- **Chemicals:** ETH (MESH:D005000)
- **Species:** Mycobacterium tuberculosis (species) [taxon 1773]
- **Mutations:** -100C>A, -777C>T, Tyr155Ser, -31G>A

---
Source: https://tomesphere.com/paper/PMC12855482